-
Rite Aid Corporation’s
RAD
shares jumped 21.4% after the company reported third-quarter 2021 earnings of 15 cents per share, beating the Zacks Consensus Estimate of a loss of 18 cents.
-
Shares of Apogee Enterprises, Inc.
APOG
rose 9.4% after the company reported third-quarter fiscal 2022 earnings of 63 cents per share, beating the Zacks Consensus Estimate of 53 cents.
-
Micron Technology, Inc.’s
MU
shares surged 10.5% after the company reported first-quarter fiscal 2022 earnings of $2.16 per share, much above the Zacks Consensus Estimate of $2.10.
-
Shares of NIKE, Inc.
NKE
jumped 6.2% after the company reported second-quarter fiscal 2022 earnings of 83 cents per share, beating the Zacks Consensus Estimate of 63 cents.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.
See these 7 breakthrough stocks now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report